Director · Forte Biosciences, Inc. · Forte Biosciences, Inc. — Stock Option (right to buy)
Side
D
Value
—
Shares
800
Price
—
Executed
Aug 27, 2026
Disclosed
Aug 27, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Aug 27 executedAug 27, 2026 disclosed
FBRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disposition to issuer — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 0 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Forte Biosciences, Inc. — Stock Option (right to buy)
Ticker
FBRX
Shares
800
Execution date (reported)
Aug 27, 2026
Owned after transaction
0 shares
Days from execution to publication
0
What this establishes
Kornfeld Steven filed this Form 4 reporting a disposition to issuer of FBRX on Aug 27, 2026. It became public on Aug 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Kornfeld Stevencik:0001814653
Issuer
Forte Biosciences, Inc.cik:0001419041
Revision history · 0
No field has changed since this record was first ingested.
